{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:01:13Z","timestamp":1787065273587,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Some studies have suggested that axillary lymph node dissection (ALND) can be avoided in women with cN0 breast cancer with 1\u20132 positive sentinel nodes (SLNs). However, these studies included only a few patients with invasive lobular carcinoma (ILC), so the validity of omitting ALDN in these patients remains controversial. This study compared the frequency of non-sentinel lymph nodes (non-SLNs) metastases in ILC and invasive ductal carcinoma (IDC). Materials Methods: Data relating to a total of 2583 patients with infiltrating breast carcinoma operated at our institution between 2012 and 2023 were retrospectively analyzed: 2242 (86.8%) with IDC and 341 (13.2%) with ILC. We compared the incidence of metastasis to SLNs and non-SLNs between the ILC and IDC cohorts and examined factors that influenced non-SLNs metastasis. Results: SLN biopsies were performed in 315 patients with ILC and 2018 patients with IDC. Metastases to the SLNs were found in 78\/315 (24.8%) patients with ILC and in 460 (22.8%) patients with IDC (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.31). The incidence of metastases to non-SLNs was significantly higher (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02) in ILC (52\/78\u201366.7%) compared to IDC (207\/460\u2009\u2212\u200945%). Multivariate analysis showed that ILC was the most influential predictive factor in predicting the presence of metastasis to non-SLNs. Conclusions: ILC cases have more non-SLNs metastases than IDC cases in SLN-positive patients. The ILC is essential for predicting non-SLN positivity in macro-metastases in the SLN. The option of omitting ALND in patients with ILC with 1\u20132 positive SLNs still requires further investigation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-024-03375-9","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T22:01:43Z","timestamp":1713304903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma"],"prefix":"10.1186","volume":"22","author":[{"given":"Calogero","family":"Cipolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nello","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tutino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u2019Agati","family":"Eleonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Gebbia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"key":"3375_CR1","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, Ashikaga T, Weaver DL, Mamounas EP, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth M, Wolmark H. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333. https:\/\/doi.org\/10.1016\/S1470-2045(10)70207-2","journal-title":"Lancet Oncol"},{"key":"3375_CR2","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F. Gennari, R. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546\u201353. https:\/\/doi.org\/10.1056\/NEJMoa012782","journal-title":"N Engl J Med"},{"key":"3375_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.breast.2012.02.012","volume":"21","author":"DE Boler","year":"2012","unstructured":"Boler DE, Uras C, Ince U, Cabioglu N. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases. Breast. 2012;21:518\u201323. https:\/\/doi.org\/10.1016\/j.breast.2012.02.012","journal-title":"Breast"},{"issue":"10","key":"3375_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA"},{"key":"3375_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","volume":"46","author":"M Thomas","year":"2019","unstructured":"Thomas M, Kelly ED, Abraham J, Kruse M. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early-stage disease. Semin Oncol. 2019;46:121\u201332. https:\/\/doi.org\/10.1053\/j.seminoncol.2019.03.002","journal-title":"Semin Oncol"},{"key":"3375_CR6","first-page":"855","volume-title":"Rosen\u2019s breast pathology","author":"SA Hoda","year":"2014","unstructured":"Hoda SA, Brogi E, Koerner FC, Rosen PP. Rosen\u2019s breast pathology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2014. pp. 855\u201392.","edition":"4"},{"key":"3375_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buchholz TA, Hortobagyi GN. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.03.111","journal-title":"J Clin Oncol"},{"issue":"3","key":"3375_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10549-010-1257-5","volume":"125","author":"D Amadori","year":"2011","unstructured":"Amadori D, Silvestrini R, De Lena M, Boccardo F, Rocca A, Scarpi E, Schittulli F, Brandi M, Maltoni R, Serra P, Ponzone R, Biglia N, Gianni L, Tienghi A, Valerio MR, Bonginelli P, Amaducci L, Faedi M, Baldini E, Paradiso A. Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1\u20133 node-positive rapidly proliferating breast cancer. Breast Cancer Res Treat. 2011;125(3):775\u201384. https:\/\/doi.org\/10.1007\/s10549-010-1257-5","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"3375_CR9","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1245\/s10434-015-4756-0","volume":"22","author":"A Roberts","year":"2015","unstructured":"Roberts A, Nofech-Mozes S, Youngson B, McCready DR, Al-Assi M, Ramkumar S, Cil T. The importance of applying ACOSOG Z0011 criteria in the axillary management of invasive lobular carcinoma: a multi-institutional cohort study. Ann Surg Oncol. 2015;22(10):3397\u2013401. https:\/\/doi.org\/10.1245\/s10434-015-4756-0","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3375_CR10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12282-018-0852-x","volume":"25","author":"Y Adachi","year":"2018","unstructured":"Adachi Y, Sawaki M, Hattori M, Yoshimura A, Gondo N, Kotani H, Iwase M, Kataoka A, Onishi S, Sugino K, Terada M, Horisawa N, Mori M, Oze I, Iwata H. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma. Breast Cancer. 2018;25(5):560\u20135. https:\/\/doi.org\/10.1007\/s12282-018-0852-x","journal-title":"Breast Cancer"},{"key":"3375_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-020-05842-9","volume":"184","author":"W Gao","year":"2020","unstructured":"Gao W, Zeng Y, Fei X, Chen X, Shen K. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis. Breast Cancer Res Treat. 2020;184:193\u2013202. https:\/\/doi.org\/10.1007\/s10549-020-05842-9","journal-title":"Breast Cancer Res Treat"},{"key":"3375_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10549-020-05565-x","volume":"180","author":"SP Corona","year":"2020","unstructured":"Corona SP, Bortul M, Scomersi S, Scomersi S, Bigal C, Bottin C, Zanconati F, Fox SB, Giudici F, Generali D. Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers. Breast Cancer Res Treat. 2020;180:735\u201345. https:\/\/doi.org\/10.1007\/s10549-020-05565-x","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3375_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.breast.2005.01.007","volume":"15","author":"C Cipolla","year":"2006","unstructured":"Cipolla C, Fricano S, Vieni S, Amato C, Napoli L, Graceffa G, Latteri S, Latteri MA. Validity of needle core biopsy in the histological characterisation of mammary lesions. Breast. 2006;15(1):76\u201380. https:\/\/doi.org\/10.1016\/j.breast.2005.01.007","journal-title":"Breast"},{"key":"3375_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0284185113493775","volume":"55","author":"G Caruso","year":"2014","unstructured":"Caruso G, Cipolla C, Costa R, Morabito A, Latteri S, Fricano S, Salerno S, Latteri MA. Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients. Acta Radiol. 2014;55:39\u201344. https:\/\/doi.org\/10.1177\/0284185113493775","journal-title":"Acta Radiol"},{"key":"3375_CR15","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1007\/s00268-008-9719-1","volume":"32","author":"C Cipolla","year":"2008","unstructured":"Cipolla C, Vieni S, Fricano S, Cabibi D, Graceffa G, Costa R, Latteri S, Latteri M. The accuracy of sentinel lymph node biopsy in the treatment of multicentric invasive breast cancer using a subareolar injection of tracer. World J Surg. 2008;32:2483\u20137. https:\/\/doi.org\/10.1007\/s00268-008-9719-1","journal-title":"World J Surg"},{"key":"3375_CR16","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.21873\/anticanres.14124","volume":"40","author":"C Cipolla","year":"2020","unstructured":"Cipolla C, Graceffa G, Cabibi D, Gangi G, Latteri M, Valerio MR, Vieni S. Current role of intraoperative frozen section examination of sentinel lymph node in early breast cancer. Anticancer Res. 2020;40:1711\u20137. https:\/\/doi.org\/10.21873\/anticanres.14124","journal-title":"Anticancer Res"},{"key":"3375_CR17","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","volume":"26","author":"BC Pestalozzi","year":"2008","unstructured":"Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Th\u00fcrlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A. International breast Cancer Study. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 international breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26:3006\u201314. https:\/\/doi.org\/10.1200\/JCO.2007.14.9336","journal-title":"J Clin Oncol"},{"key":"3375_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cance R Res. 2004;6:149\u201356. https:\/\/doi.org\/10.1186\/bcr767","journal-title":"Breast Cance R Res"},{"key":"3375_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.breast.2017.06.043","volume":"35","author":"ME Cazzaniga","year":"2017","unstructured":"Cazzaniga ME, Airoldi M, Arcangeli V, Artale S, Atzori F, Ballerio A, et al. Efficacy and safety of everolimus and exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2\u2013) advanced breast cancer patients: new insights beyond clinical trials. EVA Study Breast. 2017;35:115\u201321. https:\/\/doi.org\/10.1016\/j.breast.2017.06.043","journal-title":"EVA Study Breast"},{"key":"3375_CR20","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1245\/s10434-007-9419-3","volume":"14","author":"LA Lambert","year":"2007","unstructured":"Lambert LA, Ayers GD, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting non-sentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2007;14:2422\u20133. https:\/\/doi.org\/10.1245\/s10434-007-9419-3","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"3375_CR21","doi-asserted-by":"publisher","first-page":"7900","DOI":"10.1002\/jcp.29445","volume":"235","author":"E Krasniqi","year":"2020","unstructured":"Krasniqi E, Pizzuti L, Barchiesi G, Sergi D, Carpano S, Botti C. Impact of BMI on HER2\u2009+\u2009metastatic breast cancer patients treated with pertuzumab and\/or trastuzumab emtansine. Real-world evidence. J Cell Physiol. 2020;235(11):7900\u201310. https:\/\/doi.org\/10.1002\/jcp.29445","journal-title":"J Cell Physiol"},{"key":"3375_CR22","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/jclinpath-2011-200151","volume":"64","author":"B Fern\u00e1ndez","year":"2011","unstructured":"Fern\u00e1ndez B, Paish EC, Green AR, Lee AH, Macmillan RD, Ellis IO, Rakha EA. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast. J Clin Pathol. 2011;64:995\u20131000. https:\/\/doi.org\/10.1136\/jclinpath-2011-200151","journal-title":"J Clin Pathol"},{"issue":"1","key":"3375_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1186\/s12885-019-5823-x","volume":"19","author":"S Majid","year":"2019","unstructured":"Majid S, Ryd\u00e9n L, Manjer J. Determinants for non-sentinel node metastases in primary invasive breast cancer: a population-based cohort study of 602 consecutive patients with sentinel node metastases. BMC Cancer. 2019;19(1):626. https:\/\/doi.org\/10.1186\/s12885-019-5823-x","journal-title":"BMC Cancer"},{"key":"3375_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s10549-020-05565-x","volume":"180","author":"SP Corona","year":"2020","unstructured":"Corona SP, Bortul M, Scomersi S, Bigal C, Bottin C, Zanconati F, Fox SB, Giudici F, Generali D. Management of the axilla in breast cancer: outcome analysis in a series of ductal versus lobular invasive cancers. Breast Cancer Res Treat. 2020;180:735\u201345. https:\/\/doi.org\/10.1007\/s10549-020-05565-x","journal-title":"Breast Cancer Res Treat"},{"key":"3375_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.sla.0000150255.30665.52","volume":"241","author":"G Viale","year":"2005","unstructured":"Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, Zurrida S, Maisonneuve P, Paganelli G, Mazzarol G. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005;241:319\u201325. https:\/\/doi.org\/10.1097\/01.sla.0000150255.30665.52","journal-title":"Ann Surg"},{"key":"3375_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13058-015-0517-z","volume":"17","author":"M Christgen","year":"2015","unstructured":"Christgen M, Derksen P. Lobular breast cancer: molecular basis, mouse and cellular models. Breast Cancer Res. 2015;17:16. https:\/\/doi.org\/10.1186\/s13058-015-0517-z","journal-title":"Breast Cancer Res"},{"key":"3375_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2407-8-66","volume":"8","author":"HE Kohrt","year":"2008","unstructured":"Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S, Rouse RV, Bailey L, Philben VJ, Dirbas FM, Dunn JJ, Johnson DL, Wapnir IL, Carlson RW, Stockdale FE, Hansen NM, Jeffrey SS. & Bay Area SLN Study. New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 2008;8:66. https:\/\/doi.org\/10.1186\/1471-2407-8-66","journal-title":"BMC Cancer"},{"key":"3375_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0002-9610(01)00719-x","volume":"182","author":"SF Abdessalam","year":"2001","unstructured":"Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, Carson WB, Burak WE. Jr. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg. 2001;182:316\u201320. https:\/\/doi.org\/10.1016\/s0002-9610(01)00719-x","journal-title":"Am J Surg"},{"key":"3375_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 noninferiority trial. Lancet Oncol. 2014;15:1303\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"issue":"20","key":"3375_CR30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.21037\/atm-21-5169","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ling Y, Wang T, Yan C, Huang M, Fan Z, Ling R. Chinese Society of Breast Cancer. Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001). Ann Transl Med. 2021;9(20):1588. https:\/\/doi.org\/10.21037\/atm-21-5169","journal-title":"Ann Transl Med"},{"issue":"34","key":"3375_CR31","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/JCO.20.02514","volume":"38","author":"SRD Johnston","year":"2020","unstructured":"Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cort\u00e9s J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O\u2019Shaughnessy J. Priya Rastogi. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-nositive, high-risk, early breast bancer (monarchE). J Clin Oncol. 2020;38(34):3987\u201398.","journal-title":"J Clin Oncol"},{"key":"3375_CR32","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/cncr.21071","volume":"103","author":"RJ Santiago","year":"2005","unstructured":"Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ. Similar long-term results of breast-conservation treatment for stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer. 2005;103:2447\u201354. https:\/\/doi.org\/10.1002\/cncr.21071","journal-title":"Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03375-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03375-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T22:05:03Z","timestamp":1713305103000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03375-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03375-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,17]]},"assertion":[{"value":"13 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained according to the Italian rules for retrospective studies by communication to the Ethics Committee of the University Hospital of Palermo.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}